|
SC5DL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.15223411209809E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62547753035369E-12 |
| Normal-vs-Stage2 |
7.95249976981438E-10 |
| Normal-vs-Stage3 |
1.64835999999502E-05 |
| Normal-vs-Stage4 |
1.671840E-02 |
| Stage1-vs-Stage2 |
5.512600E-01 |
| Stage1-vs-Stage3 |
3.384000E-02 |
| Stage1-vs-Stage4 |
6.106500E-02 |
| Stage2-vs-Stage3 |
2.726400E-01 |
| Stage2-vs-Stage4 |
1.770960E-01 |
| Stage3-vs-Stage4 |
7.045800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.23234755733392E-14 |
| Normal-vs-AfricanAmerican |
1.76859971112719E-10 |
| Normal-vs-Asian |
8.658200E-01 |
| Caucasian-vs-AfricanAmerican |
4.652800E-01 |
| Caucasian-vs-Asian |
7.723100E-03 |
| AfricanAmerican-vs-Asian |
1.193580E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.99200722162641E-16 |
| Normal-vs-Female |
4.34480000000015E-06 |
| Male-vs-Female |
1.715870E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.39140000024562E-07 |
| Normal-vs-Extreme_Weight |
7.7715611723761E-16 |
| Normal-vs-Obese |
1.61690000277659E-08 |
| Normal-vs-Extreme_Obese |
9.181100E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.257500E-02 |
| Normal_Weight-vs-Obese |
9.896800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.649200E-01 |
| Extreme_Weight-vs-Obese |
7.911800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.681600E-01 |
| Obese-vs-Extreme_Obese |
9.596400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.865600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.87627691161651E-12 |
| Normal-vs-Age(61-80Yrs) |
1.22124532708767E-15 |
| Normal-vs-Age(81-100Yrs) |
6.4949999822872E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.117600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.001800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.771900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.510420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.978000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.796600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.9433999682027E-09 |
| Normal-VS-KIRP CIMP |
9.725800E-01 |
| Normal-VS-Unclassified PRCC |
9.09109998392665E-09 |
| Type1 PRCC-VS-Type2 PRCC |
2.504200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.156400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.564300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.470970E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.058000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.318430E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.57410031862571E-10 |
| Normal-vs-N1 |
1.916560E-01 |
| Normal-vs-N2 |
3.80050000003962E-06 |
| N0-vs-N1 |
6.171600E-02 |
| N0-vs-N2 |
3.826800E-01 |
| N1-vs-N2 |
6.597400E-03 |
|
|
